Personalized Movement Therapy for Chronic Pain: A4M 27th Annual World Congress

Patients with chronic pain may know that conventional therapies such as physical therapy, can benefit them to a certain extent, but definitely have their limits. DrBonnie360 is herself a longtime chronic pain patient and has amassed a great amount of research and insight into alternative movement therapies to help manage chronic pain. Check out this article to explore her presentation on personalized movement therapy from the A4M Annual World Congress.

For 35 years, DrBonnie360 has coped with chronic musculoskeletal pain, secondary to her chronic autoimmune condition and fibromyalgia. She was a faithful physical therapy patient before later discovering that there are limitations to this exercise treatment. From her personal experience and extensive research (found at the end of the presentation slides below), she discovers additional movement modalities such as pool therapy, yoga therapy, pilates therapy, Gyrotonic method, Qi Gong, Tai Chi, and Feldenkrais method that can advance mobility and provide additional long-term benefits.

To learn more about how you can use personalized movement therapy to help with chronic pain, explore DrBonnie360’s presentation at the A4M 27th Annual World Congress in Las Vegas, NV below!

Be sure to check out our other posts about movement and our e-book, A Guide to Movement Therapy, to better understand how you can use different exercises to improve your overall health and wellness!

Share:

Facebook
Twitter
Pinterest
LinkedIn
On Key

Related Posts

Our Vision of Autoimmune Care

Autoimmune Patient Journey The convoluted journey of patients with autoimmune and inflammatory diseases (AIIDs) has many stages. Unlike cancer, diabetes, and heart disease, there are no population screening nor public health education programs for AIIDs.

Autoimmune Incidence & Prevalence

Data Issues in Autoimmune Data for autoimmune diseases are substantially lacking and inconsistent. The US gathers no statistics on autoimmune diseases as a group, nor even national data on marquee diseases. Therefore, total autoimmune incidence